Targeted therapy: best clinics abroad

Targeted therapy uses medicines that act on molecular features involved in cancer growth and survival. Different drugs block different pathways or bind to particular proteins. Treatment may be taken by mouth or given by infusion, alone or alongside other cancer treatments. Its suitability depends on the diagnosis, stage, previous therapy and, for many drugs, the tumour's biomarker results. Finding a target can help select treatment but does not guarantee a response.

Patients consider care abroad to obtain a specialist review of pathology and molecular tests, discuss evidence-based options or assess eligibility for a clinical trial. A useful consultation explains why a specific medicine fits the case, its expected purpose and how adverse effects will be monitored. Before travelling, establish a continuing supply of prescribed treatment and access to tests and urgent advice after returning home. Costs depend on the medicine, testing and duration of care, not simply on an initial appointment.

Matching treatment to the cancer

Targeted drugs act on selected proteins or pathways that support cancer growth. Some are small molecules; others are antibodies. They may be used before or after local treatment or to control advanced disease. An oncology assessment considers the cancer subtype, stage, previous response and current health. A drug useful for one molecular subtype may be unsuitable for another.

Tests and preparation

Biomarker testing may use stored tumour tissue, a new biopsy or a suitable blood test. The team chooses tests relevant to the diagnosis. A finding of uncertain significance does not automatically identify a treatment. Results may change over time, so repeat testing can be appropriate when cancer progresses.

Before treatment, clinicians review blood counts, organ function and all medicines, supplements and relevant food interactions. Additional heart or other tests depend on the drug. Discuss pregnancy, fertility and planned operations. Obtain written instructions for taking oral medicines, missed doses and when to contact the team.

How treatment is given and checked

Tablets, capsules, injections or infusions follow a drug-specific schedule. Some treatments run continuously; others are given in cycles or for a defined period. Scans, clinical reviews and blood tests assess response and toxicity. The team may adjust doses, pause treatment or change the medicine when needed. Do not alter prescribed treatment independently.

Side effects and resistance

Targeted treatment can affect healthy tissue and cause serious problems. Depending on the medicine, effects include rash, diarrhoea, mouth soreness, fatigue, high blood pressure and liver abnormalities; some drugs affect the heart, lungs, clotting or wound healing. Fever, breathing difficulty, severe diarrhoea, bleeding or an allergic reaction need prompt assessment according to your emergency plan.

Cancer can develop resistance, and a suitable biomarker does not ensure lasting control. Progression may lead to another biopsy, a different drug or a combination treatment. Side effects and benefit must be reviewed together.

Care abroad and cost drivers

Clarify access to the recommended medicine, monitoring at home, test interpretation and responsibility for complications. Ask for separate estimates for pathology review, molecular tests, medicines, administration and repeated follow-up. Trial participation requires a separate eligibility assessment.

FAQ

Does every mutation have a matching drug?

No. Some findings are not actionable or lack an established treatment.

Are tablets free of serious risks?

No. Oral targeted drugs also require careful monitoring and interaction checks.

Can it replace all other treatment?

Not routinely. The plan may combine it with surgery, radiation or other medicines.